Quest Diagnostics' Q4 Revenues up 7 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Quest Diagnostics today posted a 7 percent rise in fourth quarter revenues, topping analysts' estimates and helping drive an increase in its net income.

Quest's revenues from continuing operations were $1.88 billion for the three-month period ended Dec. 31, compared with year-ago revenues of $1.76 billion. Analysts had expected revenues of $1.85 billion.

The company said revenues from diagnostic information services climbed 7 percent over last year, while test volume around 9 percent. Revenue per requisition was nearly 2 percent lower than a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.